Action SBPH SPRING BANK PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Communiqués Spring Bank Pharmaceuticals, Inc.

Actions

SBPH

US8494311017

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
F-STAR THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Spring Bank Pharmaceuticals : F-star Therapeutics Announces Approval of Clinical Trial Application for FS222
PU
Spring Bank Pharmaceuticals : F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals
PU
Spring Bank Pharmaceuticals : F-star Therapeutics to Present New Clinical and Mechanistic Data on its LAG-3/PD-L1 Tetravalent Bispecific Antibody, FS118, at the SITC 2020 Virtual Annual Meeting
PU
F-STAR THERAPEUTICS, INC. : Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Registrant's Certifying Accountant, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Spring Bank Pharmaceuticals : Stockholders Approve Combination with F-star Therapeutics
AQ
Spring Bank Pharmaceuticals : Stockholders Approve Combination with F-star Therapeutics
AQ
Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics
GL
SPRING BANK PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Spring Bank Pharmaceuticals : Announces Special Dividend of Contingent Value Rights
AQ
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights
GL
SPRING BANK PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Spring Bank Pharmaceuticals : Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer Annual Meeting
AQ
Spring Bank Pharmaceuticals : Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
AQ
Spring Bank Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
GL
SPRING BANK PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Spring Bank Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Results
GL
SPRING BANK PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
SPRING BANK PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies
GL
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action SBPH
  4. Actualités Spring Bank Pharmaceuticals, Inc.
  5. Communiqués